| 今开：1.64 | 昨收：1.63 |
| 最高：1.65 | 最低：1.56 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.6856439E7 |
Cue Biopharma(CUE)03-29 04:35
$Cue Biopharma(CUE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038084 Act: 33 Size: 146 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:45
$Cue Biopharma(CUE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038059 Act: 34 Size: 12 MB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028609 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028608 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028612 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-12 06:45
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000025 Act: 34 Size: 41 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028611 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028613 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)02-23 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-018724 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)02-08 06:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006803 Act: 34 Size: 12 KB 网页链接查看全文
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-032155 Size: 5 KB 网页链接
$Cue生物制药(CUE)$ 8-K Current report, item 1.01 Accession Number: 0001193125-20-297603 Act: 34 Size: 145 KB 网页链接
$Cue生物制药(CUE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-052490 Act: 34 Size: 7 MB 网页链接
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-027608 Size: 8 KB 网页链接
$Cue生物制药(CUE)$ 内部交易: 2020-09-30,Director,Gray Cameron ,买入,5000普通股, $15.30
$Cue生物制药(CUE)$ 内部交易: 2020-09-29,Director,Gray Cameron ,买入,5000普通股, $15.00
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-026662 Size: 6 KB 网页链接
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-051145 Size: 5 KB 网页链接
$Cue生物制药(CUE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-051142 Size: 6 KB 网页链接
$Cue生物制药(CUE)$ 8-K Current report, item 5.02 Accession Number: 0001193125-20-247622 Act: 34 Size: 145 KB 网页链接